NCT01137890
- Conditions
- Behavior, Behavior, Addictive, Chemically-Induced Disorders, +6 more
- Locations
-
- Behavioral Pharmacology Research Unit Baltimore, Maryland, United States
Clinical trial condition
Substance-Related Disorders
Explore clinical trials studying Substance-Related Disorders. Study availability and eligibility vary by location and protocol.
1,864 public trials
234 recruiting studies
Substance-Related Disorders trial results
NCT01032135
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Substance Use Disorders, +1 more
- Locations
-
- Presbyterian Medical Center Philadelphia, Pennsylvania, United States
- VAMC Philadelphia, Pennsylvania, United States
- NorthEast Treatment Center Philadelphia, Pennsylvania, United States
NCT00617201
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Substance Abuse, +1 more
- Locations
-
- Straus Research Building Lexington, Kentucky, United States
NCT03012087
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Prescription Drug Abuse, +1 more
- Locations
-
- Johns Hopkins Hospital Emergency Department Baltimore, Maryland, United States
- West Virginia University Emergency Department Morgantown, West Virginia, United States
NCT01751217
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Substance-Related Disorders, +1 more
- Locations
-
- Oregon Research Institute Center for Family and Adolescent Research Albuquerque, New Mexico, United States
Completed
Cognitive Processing Intervention for Trauma, HIV/STI Risks, and Substance Use Among Native Women
NCT01849029
- Conditions
- Alcohol Drinking, Alcohol-Related Disorders, Behavior, +12 more
- Locations
-
- Yakama Nation Behavioral Health and Comprehensive Community Alcoholism Program and Youth Treatment Program Toppenish, Washington, United States
NCT00437840
- Conditions
- Behavior, Chemically-Induced Disorders, Mental Disorders, +3 more
- Locations
-
- GSK Investigational Site Berlin, Germany
NCT00728897
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Substance Dependence, +1 more
- Locations
-
- GSK Investigational Site London, United Kingdom
Completed
Relapse Prevention With Varenicline
NCT00944554
- Conditions
- Behavior, Chemically-Induced Disorders, Disease Attributes, +8 more
- Locations
-
- Behavioral Pharmacology Research Unit Baltimore, Maryland, United States
Completed
A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers
NCT00728052
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Substance Dependence, +1 more
- Locations
-
- GSK Investigational Site Berlin, Germany